Sitemap
December 06, 2015 Articles
Filter by Available Specialty
- Daratumumab combination confers durable responses in relapsed, refractory multiple myeloma
- Hip-back symptoms require a variety of treatments
- Ixazomib prolongs PFS in relapsed, refractory multiple myeloma
- Less than half of non-VA hospitals require flu vaccination in HCWs
- LMWH dose-reduction guidelines appear safe, effective for chemotherapy-induced thrombocytopenia
- Midostaurin confers OS, EFS benefits in FLT3-mutated AML
- Novel tool identifies, colors mosquitoes carrying infectious diseases
- Prolonged red blood cell storage not linked to poorer transfusion outcomes
- Real-time protocol identifies high-risk pediatric B-ALL patients with favorable outcomes
- San Antonio Breast Cancer Symposium highlights developments in clinical, basic, translational research
- Thymidylate synthase polymorphism increases risk for bony morbidity in pediatric ALL
- Tooth loss greater for US adults with diabetes
- Warfarin transition appears tolerable in patients with cancer-associated thrombosis